<DOC>
	<DOCNO>NCT00147160</DOCNO>
	<brief_summary>The purpose study determine whether combination Temozolomide Cisplatinum effective treatment malignant glial tumour child adolescent</brief_summary>
	<brief_title>Phase II Cisplatin + Temozolomide Malignant Glial Tumours Children Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Age 4th birthday young 21st birthday Histologically document malignant glial tumour ( WHO classification grade III IV ) : astrocytoma , oligodendroglioma , oligoastrocytoma mixed tumour Measurable evaluable disease image criterion ( MRI ) Patient previously treat either two drug Malignant brain stem tumour exclude</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>